The best available treatment for chronic kidney disease from high blood pressure did not keep the disease from substantially worsening in about a fourth of African-Americans studied, according to long-term results of a National Institutes of Health study published April 28, 2008, in the Archives of Internal Medicine.
The largest and longest study of chronic kidney disease in African-Americans — the African American Study of Kidney Disease and Hypertension (AASK) — found that the disease substantially worsened in about one-fourth of participants, even with very good blood pressure control and use of kidney-protecting medications, currently the best available treatment. This subgroup of patients either lost half their kidney function or reached kidney failure, also known as end-stage renal disease.
"Despite these sobering results, blood pressure control is still vital in kidney disease and in many other diseases," said NIH Director Elias A. Zerhouni, M.D. "But this research clearly signals the importance of preventing kidney disease, better understanding causes and finding better ways to manage it in the 26 million Americans who already have it."
Good news also emerged from the study. About one-third of participants experienced a slow decline in kidney function, about what is generally observed with aging. "The factors that may be responsible for such a small loss of kidney function need to be studied," said Lawrence Y. Agodoa, M.D., senior author of the study and director of kidney failure research at NIH’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which funded the study.
The AASK Cohort Study observed about 750 African-Americans on recommended therapy for chronic kidney disease from 2002 to 2007. Study participants were initially recruited beginning in 1995 for the AASK Clinical Trial
www.nih.gov/news/pr/nov2002/niddk-25.htm, which concluded in 2001 that an ACE inhibitor medication protected the kidneys better than two other classes of blood pressure drugs. During the Cohort Study, nearly 9 out of 10 participants were taking an ACE inhibitor or an angiotensin receptor blocking drug, and average blood pressure was 133/78 mmHg, close to national guidelines for high blood pressure in people with chronic kidney disease.
Uncontrolled high blood pressure, an increase in the number of people with diabetes, and the aging of the U.S. population means more people than ever are getting and living with kidney problems. About 13 percent of the U.S. population, up from 10 percent in 1994, now have chronic kidney disease. And in 2005, more than 485,000 people were on chronic dialysis or had a kidney transplant for kidney failure, costing Medicare, private insurers and patients $32 billion.
Source: National Institute of Diabetes and Digestive and Kidney Diseases
Related stories:
Leading worldwide cause of cardiovascular disease may be modified by diet
A new article indicates that an increased intake in minerals such as potassium, and possibly magnesium and calcium by dietary means may reduce the risk of high blood pressure and decrease blood pressure in people with hypertension. A high intake of these minerals in the diet may also reduce the risk of coronary heart disease and stroke. These findings are published in a supplement appearing with the July issue of
The Journal of Clinical Hypertension.
'Smart bomb' nanoparticle strategy impacts metastasis
A new treatment strategy using molecular "smart bombs" to target metastasis with anti-cancer drugs leads to good results using significantly lower doses of toxic chemotherapy, with less collateral damage to surrounding tissue, according to a collaborative team of researchers at the University of California, San Diego.
Researchers find molecule that kills kidney cancer cells
Kidney cancer patients generally have one option for beating their disease: surgery to remove the organ.
Disclosure of organ transplant risks: A question of when, not if
University of Pennsylvania School of Medicine physicians and bioethicists are calling for a new, more standardized way for patients in need of organ transplants to be informed of the risks they face. If adopted, their policy recommendations could promote greater equity in how organs are allocated while restricting patients' abilities to "cherry-pick" the best organs.
High levels of urinary albumin in the normal range predict hypertension
Healthy individuals with higher levels of albumin excretion, even levels considered normal, are at increased risk of developing hypertension (high blood pressure), according to a study appearing in the October 2008 issue of the
Journal of the American Society Nephrology (JASN). The study suggests that to prevent cardiovascular disease, the definition of "normal" urinary albumin excretion should be reconsidered.
CDC: About 8 percent of Americans have diabetes
(AP) -- The number of Americans with diabetes has grown to about 24 million people, or roughly 8 percent of the U.S. population, the government said Tuesday.
New online care for hypertension gets results
Controlling blood pressure at home, on Web, nearly doubles proportion of successful patients, JAMA study reports
Web-based care and at-home blood pressure checks can help control hypertension without office visits, according to the "e-BP" (Electronic Blood Pressure) study of more than 700 Group Health patients published in the June 25
Journal of the American Medical Association.
Home blood pressure monitoring plus Web-based pharmacy care helps improve blood pressure control
Patients with hypertension who monitored their blood pressure from home and received Web-based pharmacist care showed greater improvement in blood pressure control than patients who received usual care, according to a study in the June 25 issue of
JAMA.